Condition
Depression, Involutional
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT00078715Phase 2CompletedPrimary
Rapid Antidepressant Effects of Yohimbine in Major Depression
NCT00084162CompletedPrimary
Neurocardiac Control in Major Depression
NCT00033787CompletedPrimary
Serotonin Function During Depression
NCT00001916Completed
Use of Bone Biopsy to Better Understand the Causes of Decreased Bone Mineral Density in Depression
Showing all 4 trials